 MELBOURNE, Australia, July 09, 2021 GLOBE NEWSWIRE -- Genetic Technologies Limited ASX: GTG, NASDAQ: GENE, Company, GTG, a diversified Genomics and AI driven preventative health business, today announced updates on the development of its Predictive Panel Risk Test designed to cover six different cancers including breast and colorectal cancer, prostate and ovarian cancer, pancreatic cancer and melanoma. 